mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.07 |
mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.07 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.07 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.07 |
mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.08 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.08 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.08 |
mRNA |
AZD1480 |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.08 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.08 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.08 |